1. Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India

   • Ruchika Gangawar
   • Dinesh Ahirwar
   • Rama Devi Mittal

   Original Paper 26 February 2009 Pages: 159 - 166

   

2. Treatment of NonHodgkin’s lymphomas with rituximab in Slovene patients

   • Barbara Jezeršek Novaković
   • Ana Benigar

   Original Paper 05 March 2009 Pages: 167 - 176

   

3. Glucose metabolism disorders in cancer patients in a Chinese population

   • Ya-Shi Zhan
   • Lie Feng
   • Xian-Ming Pu

   Original Paper 05 March 2009 Pages: 177 - 184

4. TNF-α and its inhibitors in cancer

   • Inès Zidi
   • Souhir Mestiri
   • Nidhal Ben Amor

   Original Paper 11 March 2009 Pages: 185 - 198

   

5. Mean platelet volume increase after tamoxifen, but not after anastrazole in adjuvant therapy of breast cancer

   • Bülent Karagöz
   • Oğuz Bilgi
   • Emin Gökhan Kandemir

   Original Paper 05 March 2009 Pages: 199 - 202

6. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery

   • Qi-Hong Zhao
   • Ying Zhang
   • Long-Ping Wen

   Original Paper 12 March 2009 Pages: 203 - 212

   

7. Analysis of a case with disappearance of the primary gastrointestinal stromal tumor and progressive liver metastases under long-term treatment with tyrosine kinase inhibitors

   • Silke Cameron
   • Theodoros Savvoukidis
   • Giuliano Ramadori

   Original Paper 18 March 2009 Pages: 213 - 218

   

8. Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue

   • Jin Wang
   • Yong-Hong Yang
   • Dong Wang

   Original Paper 17 March 2009 Pages: 219 - 223

   

9. Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis

   • M. Bonomi
   • R. Nortilli
   • G. L. Cetto

   Original paper 28 March 2009 Pages: 224 - 229

10. ¹⁸F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma

    • A. Azad
    • G. Chong
    • N. C. Tebbutt

    Original Paper 19 March 2009 Pages: 230 - 232

    

11. Intraoperative touch imprint cytology of sentinel lymph nodes in breast cancer: experience at a tertiary care center in Mexico

    • V. M. Pérez-Sánchez
    • T. A. Vela-Chávez
    • I. Zeichner-Gancz

    Original Paper 19 March 2009 Pages: 233 - 236

12. Prognostic factors in patients with small cell lung carcinoma

    • S. Arinc
    • U. Gonlugur
    • A. Hazar

    Original Paper 28 April 2009 Pages: 237 - 241

13. Risk stratification for recurrence in patients with esophageal and junctional carcinoma treated with neoadjuvant chemotherapy and surgery

    • S. Dixit
    • M. Tilston
    • W. M. Peter

    Original Paper 24 March 2009 Pages: 242 - 248

    

14. Primary colorectal lymphoma

    • Khaled M. Musallam
    • Hasan A. Hatoum
    • Ali I. Shamseddine

    Original Paper 20 March 2009 Pages: 249 - 254

    

15. The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma

    • Ledu Zhou
    • Yun Huang
    • Zhiming Wang

    Original Paper 20 March 2009 Pages: 255 - 261

    

16. CHOP-21 for unfavorable Hodgkin’s lymphoma. An exploratory study

    • Jan Walewski
    • Elżbieta Lampka
    • Janusz Meder

    Original Paper 25 March 2009 Pages: 262 - 267

    

17. Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer

    • Suzana Kukulj
    • Morana Jaganjac
    • Marija Poljak-Blazi

    Original Paper 24 March 2009 Pages: 268 - 277

    

18. 5-Aza-2′-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1

    • Min Cui
    • Zeqing Wen
    • Hualing Zhang

    Original Paper 21 March 2009 Pages: 278 - 285

    

19. T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience

    • Aleksandra Sretenovic
    • Darko Antic
    • Biljana Mihaljevic

    Original Paper 21 March 2009 Pages: 286 - 290

20. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy

    • Angelo Zullo
    • Cesare Hassan
    • Sergio Morini

    Original Paper 24 March 2009 Pages: 291 - 295

21. Identification of human gastric carcinoma biomarkers by differential protein expression analysis using ¹⁸O labeling and NanoLC-MS/MS coupled with laser capture microdissection

    • Zhang ZhiQiang
    • Li MaoYu
    • Chen ZhuChu

    Original Paper 28 March 2009 Pages: 296 - 303

    

22. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer

    • Yan-Lei Ma
    • Jia-Yuan Peng
    • Huan-Long Qin

    Original Paper 02 April 2009 Pages: 304 - 309

    

23. Diffuse large B-cell lymphoma: experience from a tertiary care center in north India

    • Rohan Khera
    • Snigdha Jain
    • R. Dawar

    Original Paper 07 April 2009 Pages: 310 - 318

    

24. Interstitial ¹²⁵I seeds implantation to treat spinal metastatic and primary paraspinal malignancies

    • Junjie Wang
    • Huishu Yuan
    • Ruijie Yang

    Original Paper 10 April 2009 Pages: 319 - 326

    

25. Intensive chemotherapy failure in Burkitt’s lymphoma with cavernous sinus involvement

    • Zhi-Yu Chen
    • Bin Wu
    • Ji-Liang Yin

    Original Paper 14 April 2009 Pages: 327 - 331

    

26. Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients

    • Eleni M. Karapanagiotou
    • Evangelos Terpos
    • Kostas N. Syrigos

    Original Paper 17 April 2009 Pages: 332 - 338

27. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population

    • Jin-song Hu
    • De-wu Wu
    • Xiong-yin Miao

    Original Paper 28 April 2009 Pages: 339 - 345

    

28. Comparative proteome analysis of human adenocarcinoma

    • Gaoming Xiao
    • Qionghui Lu
    • Zhiqiang Xiao

    Original Paper 21 April 2009 Pages: 346 - 356

    

29. Platelet count: association with prognosis in lung cancer

    • Francisco Javier Gonzalez Barcala
    • Jose Maria Garcia Prim
    • Luis Valdes Cuadrado

    Original Paper 21 April 2009 Pages: 357 - 362

    

30. Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy

    • Thomas Nelius
    • Tobias Klatte
    • Stephanie Filleur

    Original Paper 14 April 2009 Pages: 363 - 367

    

31. A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma

    • Larry E. Puls
    • Bunny Phillips
    • David Griffin

    Original Paper 21 April 2009 Pages: 368 - 372

32. Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma

    • Holger Gerullis
    • Lothar Bergmann
    • Thomas Otto

    Original Paper 28 April 2009 Pages: 373 - 378

33. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells

    • Shuanglin Xiang
    • Zhenhua Sun
    • Jian Zhang

    Original Paper 08 May 2009 Pages: 379 - 387

    

34. Preoperative serum leptin levels in patients with breast cancer

    • Mehmet Aliustaoglu
    • Ahmet Bilici
    • Mustafa Yaylaci

    Original Paper 02 May 2009 Pages: 388 - 391

35. Salvage chemotherapy with amrubicin and platinum for relapsed thymic carcinoma: experience in six cases

    • Tomonobu Koizumi
    • Toshihiko Agatsuma
    • Tsutomu Hachiya

    Original Paper 05 May 2009 Pages: 392 - 396

    

36. Overexpression of FADD enhances 5-fluorouracil-induced apoptosis in colorectal adenocarcinoma cells

    • Anning Yin
    • Yingan Jiang
    • Hesheng Luo

    Original Paper 05 May 2009 Pages: 397 - 405

    

37. Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin

    • Guo-Qing Chen
    • Zhi-Wei Zhao
    • Hui-Jun Yang

    Original Paper 02 May 2009 Pages: 406 - 415

    

38. 5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels

    • Taflan Salepci
    • Mesut Seker
    • Mustafa Yaylaci

    Original Paper 05 May 2009 Pages: 416 - 420

    

39. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy

    • Jun Jie Wang
    • Hui Shu Yuan
    • Rui Jie Yang

    Original Paper 05 May 2009 Pages: 421 - 429

    

40. Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study

    • Wai M. Liu
    • Shiyam Nizar
    • Angus G. Dalgleish

    Original Paper 12 May 2009 Pages: 430 - 433

    

41. Isolated renal relapse of a case with non-Hodgkin’s lymphoma

    • H. Mehmet Turk
    • Ahmet Ozet
    • Mukerrem Safali

    Original Paper 13 May 2009 Pages: 434 - 438

    

42. New targets of PS-341: BAFF and APRIL

    • Wuping Li
    • Juan Li
    • Shaokai Luo

    Original Paper 19 May 2009 Pages: 439 - 445

    

43. Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma

    • Thomas Gregory
    • Olivier Mir
    • Stéphane Oudard

    Original Paper 15 May 2009 Pages: 446 - 448

    

44. Clinical features of the most common fusion genes in childhood acute lymphoblastic leukemia

    • J. Lazic
    • N. Tosic
    • D. Janic

    Original Paper 02 June 2009 Pages: 449 - 453

45. Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience

    • Bala Basak Oven Ustaalioglu
    • Mahmut Gumus
    • Nazim Serdar Turhal

    Original Paper 02 June 2009 Pages: 454 - 458

    

46. Expression of MET in alveolar soft part sarcoma

    • Hyun Jung Jun
    • Jeeyun Lee
    • Yoon-La Choi

    Original Paper 27 May 2009 Pages: 459 - 465

    

47. Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response

    • Malathy P. V. Shekhar
    • Laura A. Biernat
    • Daniel W. Visscher

    Original Paper 23 May 2009 Pages: 466 - 473

    

48. Autocrine human growth hormone expression leads to resistance of MCF-7 cells to tamoxifen

    • Majid Mojarrad
    • Majid Momeny
    • Mohammad Hussein Modarressi

    Original Paper 27 May 2009 Pages: 474 - 480

    

49. Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report

    • Umut Demirci
    • Fatma Buğdaycı
    • Uğur Coşkun

    Original Paper 27 May 2009 Pages: 481 - 483

    

50. Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

    • Xin Wang
    • Jun Zhao
    • Jie Wang

    Original Paper 02 June 2009 Pages: 484 - 490